E-mail us:
service@prospectnews.com
Or call: 212 374 2800
Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
Add to balance / Manage account
Not logged in
Prospect News home
>
Main news index
>
All issuers starting with C
>
Issuers starting with C, BK only
>
All stories on Clinigen Group plc
>
Stories on Clinigen Group plc, BK only
Search again
Enter part or all of the issuer name:
Market:
All markets
No structured products
Bank loans
Canadian bonds
CLOs
Convertibles
Distressed debt
Emerging markets
High yield
Investment grade
Liability management
Municipals
PIPEs
Preferreds
Private placements
All leveraged markets
Structured products
Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each.
All others are $1.00 each. Headlines in
gray
are not currently covered by your subscription.
Clinigen Group plc
1/29/2025
BK
Clinigen finalizes €635 million term loan at Euribor plus 375 bps
1/23/2025
BK
Clinigen launches €635 million term loan at Euribor plus 375-400 bps
6/10/2024
BK
Clinigen firms €635 million term loan B at Euribor plus 425 bps
6/7/2024
BK
Fitch revises Clinigen outlook to stable
6/3/2024
BK
Clinigen readies launch of €635 million term loan B for Tuesday
4/12/2022
BK
Fitch gives Clinigen B, loans B+, CCC+
4/8/2022
BK
Moody's assigns B2 to Clinigen
4/8/2022
BK
S&P rates Triley Midco B, loans B+, CCC+
1/18/2022
BK
Triton's increased offer for Clinigen involves more banks in financing
4/24/2015
BK
Clinigen gets five-year £45 million term loan, £95 million revolver
©2025 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.
